No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / therapeutic use*
-
Breast Neoplasms / chemistry
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / pathology
-
Carcinoma, Lobular / chemistry
-
Carcinoma, Lobular / drug therapy*
-
Carcinoma, Lobular / pathology
-
Chemotherapy, Adjuvant
-
Female
-
Humans
-
Mastectomy
-
Neoplasm Metastasis
-
Radiotherapy, Adjuvant
-
Receptor, ErbB-2 / analysis
-
Receptor, ErbB-2 / antagonists & inhibitors
-
Time Factors
-
Trastuzumab
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
ERBB2 protein, human
-
Receptor, ErbB-2
-
Trastuzumab